With an estimated carrier frequency upward of ~6% (8, 15), nonreference AAGGG/CCCTT repeat expansions in RFC1 are potentially notable contributors to neurologic disease, including both ataxia and sensory neuronopathy. Here, RFC1 is linked to nervous system disorder.